Sight Sciences, Inc.

SGHT

NASDAQ

Healthcare

Medical - Devices

Menlo Park, CA, US216 employeessightsciences.com

$3.51

-0.15(-4.10%)

Mkt Cap $190M

$2.09

$9.05

52-Week Range

At a Glance

AI-generated

Sight Sciences reported FY 2025 revenue of $77.4 million, generating a gross profit of $66.7 million.

Revenue breakdown: Surgical Glaucoma (96.4%), Dry Eye (3.6%).

8-K

Sight Sciences announced a Delaware District Court order upholding a jury verdict of willful patent infringement by Alcon, awarding damages and ongoing royalties.

$190M

Market Cap

$79M

Revenue

-$39M

Net Income

Employees216

Fundamentals

How The Business Makes Money

Revenue by Segment

Surgical Glaucoma96.4%($152M)

Dry Eye3.6%($6M)

Activity

What Changed Recently

Financial Results

Mar 3, 2026

, Item 7.01, Exhibit 99.1 and Exhibit 99.2 of this Current Report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934,

Material Agreement

Feb 2, 2026

Entry into a Material Definitive Agreement On January 29, 2026, Sight Sciences, Inc. (the “Company”) entered into that certain Second Amendment to Multi-Tenant

Financial Results

Jan 12, 2026

by reference. The information provided in this Item 2.02, including Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the

Regulation FD

Mar 29, 2026

by reference. The information in Item 7.01 of this Current Report, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of Se

Peer Companies

Company	Price	Change	Market Cap	P/E
VMDViemed Healthcare, Inc.	$9.63	+0.47%	$372M	23.4
CERSCerus Corporation	$1.87	-0.27%	$359M	-22.2
SENSSenseonics Holdings, Inc.	$6.88	+3.46%	$287M	-3.9
MASS908 Devices Inc.	$6.64	+6.92%	$248M	11.4
CVRXCVRx, Inc.	$9.05	-0.55%	$238M	-4.1
OMIOMI	$2.68	+8.94%	$207M	—
PRQRProQR Therapeutics N.V.	$1.72	+0.29%	$181M	-3.3
QTRXQuanterix Corporation	$3.74	+7.47%	$176M	-1.7

Analyst View

Company Profile

CIK0001531177

ISINUS82657M1053

CUSIP82657M105

Phone877 266 1144

Address4040 Campbell Avenue, Menlo Park, CA, 94025, US

SEC EDGAR